TY - JOUR
T1 - The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse
AU - Saxena, Vijay
AU - Ondr, Jennifer K.
AU - Magnusen, Albert F.
AU - Munn, David H.
AU - Katz, Jonathan D.
PY - 2007/10/15
Y1 - 2007/10/15
N2 - Islet Ag-specific CD4+ T cells receive antigenic stimulation from MHC class II-expressing APCs. Herein, we delineate the direct in vivo necessity for distinct subsets of macrophages and dendritic cells (DC) in type 1 diabetes mellitus of the NOD mouse by using diphtheria toxin-mediated cell ablation. The ablation of macrophages had no impact on islet Ag presentation or on the induction of insulitis or diabetes in either transfer or spontaneous models. However, the ablation of CD11b+CD11c+ DC led to the loss of T cell activation, insulitis, and diabetes mediated by CD4 + T cells. When the specific myeloid DC subset was "added-back" to mice lacking total DC, insulitis and diabetes were restored. Interestingly, when NOD mice were allowed to progress to the insulitis phase, the ablation of DC led to accelerated insulitis. This accelerated insulitis was mediated by the loss of plasmacytoid DC (pDC). When pDC were returned to depleted mice, the localized regulation of insulitis was restored. The loss of pDC in the pancreas itself was accompanied by the localized loss of IDO and the acceleration of insulitis. Thus, CD11c+CD11b+ DC and pDC have countervailing actions in NOD diabetes, with myeloid DC providing critical antigenic stimulation to naive CD4+ T cells and pDC providing regulatory control of CD4+ T cell function in the target tissue.
AB - Islet Ag-specific CD4+ T cells receive antigenic stimulation from MHC class II-expressing APCs. Herein, we delineate the direct in vivo necessity for distinct subsets of macrophages and dendritic cells (DC) in type 1 diabetes mellitus of the NOD mouse by using diphtheria toxin-mediated cell ablation. The ablation of macrophages had no impact on islet Ag presentation or on the induction of insulitis or diabetes in either transfer or spontaneous models. However, the ablation of CD11b+CD11c+ DC led to the loss of T cell activation, insulitis, and diabetes mediated by CD4 + T cells. When the specific myeloid DC subset was "added-back" to mice lacking total DC, insulitis and diabetes were restored. Interestingly, when NOD mice were allowed to progress to the insulitis phase, the ablation of DC led to accelerated insulitis. This accelerated insulitis was mediated by the loss of plasmacytoid DC (pDC). When pDC were returned to depleted mice, the localized regulation of insulitis was restored. The loss of pDC in the pancreas itself was accompanied by the localized loss of IDO and the acceleration of insulitis. Thus, CD11c+CD11b+ DC and pDC have countervailing actions in NOD diabetes, with myeloid DC providing critical antigenic stimulation to naive CD4+ T cells and pDC providing regulatory control of CD4+ T cell function in the target tissue.
UR - http://www.scopus.com/inward/record.url?scp=38449111402&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=38449111402&partnerID=8YFLogxK
U2 - 10.4049/jimmunol.179.8.5041
DO - 10.4049/jimmunol.179.8.5041
M3 - Article
C2 - 17911589
AN - SCOPUS:38449111402
SN - 0022-1767
VL - 179
SP - 5041
EP - 5053
JO - Journal of Immunology
JF - Journal of Immunology
IS - 8
ER -